Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma

References

• Kubo Y, Okuda K, Musha H, Nakashima T. Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients. Gastroenterology 1978;74:578–82.
   PubMedGoogle Scholar
• Obata H, Hayashi N, Motoike Y, Hisamitsu T, Okuda H, Kobayashi S, A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 1980;25:741–7.
   PubMed Web of Science ®Google Scholar
• Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984;86:495–502.
   PubMed Web of Science ®Google Scholar
• Chen DS, Sheu JC, Sung JL, Lai MY, Lee CS, Su CT, Small hepatocellular carcinoma-a clinicopathological study in thirteen patients. Gastroenterology 1982;83:1109–19.
   PubMedGoogle Scholar
• Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434–40.
   PubMed Web of Science ®Google Scholar
• Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018–22.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907–17.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–9.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734–9.
   PubMed Web of Science ®Google Scholar
• Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164–71.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003;37:429–42.
   PubMed Web of Science ®Google Scholar
• Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2002;17:52–8.
   PubMed Web of Science ®Google Scholar
• Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259–66.
   PubMed Web of Science ®Google Scholar
• Okazaki N, Yoshino M, Yoshida T, Suzuki M, Moriyama N, Takayasu K, Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report. Cancer 1989;63:2207–10.
   PubMed Web of Science ®Google Scholar
• Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132–7.
   PubMed Web of Science ®Google Scholar
• Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289–98.
   PubMed Web of Science ®Google Scholar
• Ebara M, Hatano R, Fukuda H, Yoshikawa M, Sugiura N, Saisho H. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepato-gastroenterology 1998;45(Suppl 3):1214–20.
   PubMedGoogle Scholar
• Kubota K, Ina H, Okada Y, Irie T. Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 2003;48:581–6.
   PubMed Web of Science ®Google Scholar
• Yoshino M. Growth kinetics of hepatocellular carcinoma. Jpn J Clin Oncol 1983;13:45–52.
   PubMedGoogle Scholar
• Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol 2004;54:415–20.
   PubMedGoogle Scholar
• Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421–30.
   PubMed Web of Science ®Google Scholar
• Sherman M. Diagnosis of small hepatocellular carcinoma. Hepatology 2005;42:14–16.
   PubMedGoogle Scholar
• Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005;42:27–34.
   PubMed Web of Science ®Google Scholar
• Collins VP, Loeffler RK, Tivey H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 1956;76:988–1000.
   PubMed Web of Science ®Google Scholar
• Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 1961;14:1272–94.
   PubMed Web of Science ®Google Scholar
• Okada S, Okazaki N, Nose H, Aoki K, Kawano N, Yamamoto J, Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time. Hepato-gastroenterology 1993;40:311–5.
   PubMedGoogle Scholar
• Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095–100.
   PubMedGoogle Scholar
• Park Y, Choi D, Lim HK, Rhim H, Kim Y, Kim SH, Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT. AJR Am J Roentgenol 2008;191:215–20.
   PubMedGoogle Scholar
• Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004;127:S159–66.
   PubMed Web of Science ®Google Scholar
• Baron RL, Oliver JH, 3rd, Dodd GD, 3rd, Nalesnik M, Holbert BL, Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 1996;199:505–11.
   PubMedGoogle Scholar
• Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001;218:763–7.
   PubMedGoogle Scholar
• Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580–7.
   PubMedGoogle Scholar
• Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 1995;22:101–5.
   PubMedGoogle Scholar
• Tezuka M, Hayashi K, Kubota K, Sekine S, Okada Y, Ina H, Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma. Dig Dis Sci 2007;52:783–8.
   PubMed Web of Science ®Google Scholar